Search

everythinglearnresearchcommunity

for

Search:↓

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Immune activities and specific genes are important in male pattern baldness.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

taVNS reduces vitiligo symptoms in mice.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

Activating TERT in mice skin boosts hair growth by waking up hair follicle stem cells.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Angelica sinensis helps repair and regenerate the thymus in mice.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

DNA methylation likely doesn't cause different lambskin patterns in Hu sheep.

New therapies are being developed that target integrin pathways to treat various diseases.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

Lack of vitamin D receptor causes hair loss in mice by allowing certain genes to overactivate.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.